Strata Skin Sciences Cash Flow from Investing Activities 2010-2024 | SSKN
Strata Skin Sciences cash flow from investing activities from 2010 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
| Strata Skin Sciences Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2023 | $-5 |
| 2022 | $-4 |
| 2021 | $-7 |
| 2020 | $-2 |
| 2019 | $-3 |
| 2018 | $-2 |
| 2017 | $-2 |
| 2016 | $-1 |
| 2015 | $-44 |
| 2014 | $0 |
| 2013 | $-5 |
| 2012 | $-6 |
| 2011 | $-0 |
| 2010 | $-1 |
| 2009 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.014B | $0.033B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $35.947B | 19.74 |
| Inspire Medical Systems (INSP) | United States | $4.693B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.102B | 0.00 |
| Axonics (AXNX) | United States | $3.425B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.987B | 0.00 |
| Azenta (AZTA) | United States | $2.753B | 154.79 |
| IRhythm Technologies (IRTC) | United States | $2.730B | 0.00 |
| Enovis (ENOV) | United States | $2.727B | 20.21 |
| 10x Genomics (TXG) | United States | $2.705B | 0.00 |
| Privia Health (PRVA) | United States | $2.062B | 115.20 |
| Schrodinger (SDGR) | United States | $1.607B | 0.00 |
| Omnicell (OMCL) | United States | $1.488B | 51.43 |
| Phreesia (PHR) | United States | $1.296B | 0.00 |
| Standard BioTools (LAB) | United States | $0.936B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.647B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.645B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.501B | 0.00 |
| Talkspace (TALK) | United States | $0.480B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.403B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| Pulmonx (LUNG) | United States | $0.311B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.217B | 0.00 |
| Outset Medical (OM) | United States | $0.206B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.171B | 0.00 |
| TruBridge (TBRG) | United States | $0.146B | 7.87 |
| American Well (AMWL) | United States | $0.128B | 0.00 |
| 111 (YI) | China | $0.109B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.102B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.080B | 0.00 |
| HeartBeam (BEAT) | United States | $0.077B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.068B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.057B | 0.00 |
| Augmedix (AUGX) | United States | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.046B | 0.00 |
| CareCloud (CCLD) | United States | $0.044B | 0.00 |
| Movano (MOVE) | United States | $0.040B | 0.00 |
| Akili (AKLI) | United States | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| Cue Health (HLTH) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |